These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12044791)

  • 1. Cyclosporin A inhibits angiotensin II-induced c-Jun NH(2)-terminal kinase activation but not protein synthesis in vascular smooth muscle cells.
    Saito S; Frank GD; Motley ED; Utsunomiya H; Inagami T; Eguchi S
    Eur J Pharmacol; 2002 May; 443(1-3):47-50. PubMed ID: 12044791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
    Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
    Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK.
    Eguchi S; Dempsey PJ; Frank GD; Motley ED; Inagami T
    J Biol Chem; 2001 Mar; 276(11):7957-62. PubMed ID: 11116149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
    Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells.
    Yoshimoto T; Fukai N; Sato R; Sugiyama T; Ozawa N; Shichiri M; Hirata Y
    Endocrinology; 2004 Jul; 145(7):3331-7. PubMed ID: 15070851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-beta in angiotensin II-stimulated vascular smooth muscle cells.
    Frank GD; Eguchi S; Motley ED; Sasaki T; Inagami T
    Biochem Biophys Res Commun; 2001 Aug; 286(4):692-6. PubMed ID: 11520052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells.
    Taniyama Y; Ushio-Fukai M; Hitomi H; Rocic P; Kingsley MJ; Pfahnl C; Weber DS; Alexander RW; Griendling KK
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C494-9. PubMed ID: 15084475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
    Won SM; Park YH; Kim HJ; Park KM; Lee WJ
    Exp Mol Med; 2006 Oct; 38(5):525-34. PubMed ID: 17079869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
    Zhou CH; Wu XH; Wu YQ
    Eur J Pharmacol; 2009 Aug; 615(1-3):55-60. PubMed ID: 19486902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells.
    Goetze S; Xi XP; Graf K; Fleck E; Hsueh WA; Law RE
    FEBS Lett; 1999 Jun; 452(3):277-82. PubMed ID: 10386606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy.
    Ushio-Fukai M; Alexander RW; Akers M; Griendling KK
    J Biol Chem; 1998 Jun; 273(24):15022-9. PubMed ID: 9614110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.
    White M; Montezano AC; Touyz RM
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):5-14. PubMed ID: 22184128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of genistein and staurosporine on angiotensin II-induced DNA synthesis, protein synthesis and mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Hanada M; Saito E; Kambe T; Hagiwara Y; Kubo T
    Biol Pharm Bull; 1998 Oct; 21(10):1045-9. PubMed ID: 9821807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta.
    Ishihata A; Tasaki K; Katano Y
    Eur J Pharmacol; 2002 Jun; 445(3):247-56. PubMed ID: 12079690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway.
    Kanda Y; Mizuno K; Kuroki Y; Watanabe Y
    Br J Pharmacol; 2001 Apr; 132(8):1657-64. PubMed ID: 11309236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-induced MAPK phosphorylation mediated by Ras and/or phospholipase C-dependent phosphorylations but not by protein kinase C phosphorylation in cultured rat vascular smooth muscle cells.
    Cetin A; Ozturk OH; Tokay A; Akçit F; Cağlar S; Yeşilkaya A
    Pharmacology; 2007; 79(1):27-33. PubMed ID: 17135774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
    Watts SW; Florian JA; Monroe KM
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.